US Stock MarketDetailed Quotes

ALTS ALT5 Sigma

Watchlist
  • 2.310
  • +0.050+2.21%
Close Nov 29 13:00 ET
  • 2.367
  • +0.057+2.47%
Post 17:01 ET
32.50MMarket Cap-471P/E (TTM)

About ALT5 Sigma Company

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

Company Profile

SymbolALTS
Company NameALT5 Sigma
Listing DateFeb 22, 2006
Founded1976
CEOMr. Peter Tassiopoulos
MarketNASDAQ
Employees5
Fiscal Year Ends12-28
Address325 East Warm Springs Road,Suite 102
CityLas Vegas
ProvinceNevada
CountryUnited States of America
Zip Code89119-4238
Phone1-702-997-5968

Company Executives

  • Name
  • Position
  • Salary
  • Peter Tassiopoulos
  • Chief Executive Officer
  • --
  • Virland A. Johnson
  • Chief Financial Officer and Principal Accounting Officer
  • 349.35K
  • Tony Isaac
  • Chairman on the Board, Treasurer, President and Secretary
  • 817.71K
  • Richard D. Butler,Jr
  • Independent Director
  • 30.00K
  • Ron Pitters
  • Independent Director
  • --
  • Nael Hajjar
  • Independent Director
  • 14.40K
  • John Bitar
  • Independent Director
  • 18.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data